Form 4: HealthStream Director Sells Shares Under 10b5-1 Plan

HealthStream Inc. Director Linda Rebrovick has sold 6,000 shares of common stock, valued at approximately $174,000, as part of a pre-arranged trading plan.

Summary

• Director Linda Rebrovick sold 6,000 shares of HealthStream Inc. common stock.
• The transaction occurred on July 6, 2026.
• The sale was executed at a price of $29 per share.
• Following the transaction, Rebrovick beneficially owns 51,329 shares of common stock.
• The sale was made under a Rule 10b5-1 trading plan adopted on November 21, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While it involves a director selling shares, the sale was conducted under a pre-established Rule 10b5-1 plan, indicating it was planned in advance and not based on recent non-public information.

Negatives

• Director Linda Rebrovick sold a significant number of shares (6,000) of company stock.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future company performance. It solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider selling, especially under a Rule 10b5-1 plan, is a common practice for executives to diversify holdings or manage personal finances. While not inherently negative, a significant sale by a director can sometimes be interpreted by the market as a lack of confidence, though the pre-arranged nature of this sale mitigates that concern.

Stakeholder Impact

• Shareholders: The sale of shares by a director may be perceived by some shareholders as a negative signal, although the Rule 10b5-1 plan suggests it was pre-planned and not indicative of immediate concerns about the company's prospects.

Key Dates

Keywords

HealthStream Inc., HSTM, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Director Transaction